Geode Capital Management, LLC Axogen, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 978,896 shares of AXGN stock, worth $13.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

978,896

Previous 930,810 5.17%

Holding current value

$13.5 Million

Previous $7.51 Million 5.65%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$5.67 - $8.06 $272,647 - $387,573	48,086 Added 5.17%	978,896 $7.09 Million
Q1 2024 May 13, 2024	BUY	$6.63 - $10.69 $228,562 - $368,527	34,474 Added 3.85%	930,810 $7.51 Million
Q4 2023 Feb 13, 2024	BUY	$3.61 - $7.76 $171,810 - $369,321	47,593 Added 5.61%	896,336 $6.12 Million
Q3 2023 Nov 13, 2023	BUY	$4.68 - $9.26 $125,260 - $247,843	26,765 Added 3.26%	848,743 $4.24 Million
Q2 2023 Aug 11, 2023	BUY	$8.5 - $10.38 $298,290 - $364,265	35,093 Added 4.46%	821,978 $7.5 Million
Q1 2023 May 15, 2023	BUY	$7.53 - $10.95 $237,368 - $345,176	31,523 Added 4.17%	786,885 $7.44 Million
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $126,382 - $175,248	13,388 Added 1.8%	755,362 $7.54 Million
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $170,069 - $255,939	20,893 Added 2.9%	741,974 $8.84 Million
Q2 2022 Aug 12, 2022	BUY	$6.99 - $10.0 $231,131 - $330,660	33,066 Added 4.81%	721,081 $5.91 Million
Q1 2022 May 13, 2022	BUY	$7.26 - $10.7 $80,056 - $117,988	11,027 Added 1.63%	688,015 $5.46 Million
Q4 2021 Feb 11, 2022	BUY	$8.8 - $16.0 $588,860 - $1.07 Million	66,916 Added 10.97%	676,988 $6.34 Million
Q3 2021 Nov 12, 2021	SELL	$15.23 - $21.72 $219,342 - $312,811	-14,402 Reduced 2.31%	610,072 $9.64 Million
Q2 2021 Aug 13, 2021	BUY	$17.8 - $23.5 $477,200 - $630,011	26,809 Added 4.49%	624,474 $13.5 Million
Q1 2021 May 12, 2021	BUY	$17.18 - $22.6 $974,896 - $1.28 Million	56,746 Added 10.49%	597,665 $12.1 Million
Q4 2020 Feb 12, 2021	BUY	$11.5 - $17.96 $207,310 - $323,764	18,027 Added 3.45%	540,919 $9.68 Million
Q3 2020 Nov 13, 2020	SELL	$10.62 - $13.12 $103,778 - $128,208	-9,772 Reduced 1.83%	522,892 $6.08 Million
Q2 2020 Aug 13, 2020	BUY	$7.35 - $10.81 $234,354 - $344,676	31,885 Added 6.37%	532,664 $4.92 Million
Q1 2020 May 14, 2020	BUY	$8.38 - $17.34 $224,257 - $464,035	26,761 Added 5.65%	500,779 $5.21 Million
Q4 2019 Feb 13, 2020	BUY	$11.18 - $18.6 $156,475 - $260,325	13,996 Added 3.04%	474,018 $8.48 Million
Q3 2019 Nov 12, 2019	BUY	$12.09 - $20.46 $171,678 - $290,532	14,200 Added 3.19%	460,022 $5.74 Million
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $537,295 - $739,725	29,043 Added 6.97%	445,822 $8.83 Million
Q1 2019 May 14, 2019	BUY	$14.62 - $22.13 $489,784 - $741,377	33,501 Added 8.74%	416,779 $8.78 Million
Q4 2018 Feb 13, 2019	BUY	$17.09 - $38.25 $480,416 - $1.08 Million	28,111 Added 7.91%	383,278 $7.83 Million
Q3 2018 Nov 13, 2018	BUY	$34.05 - $55.9 $740,349 - $1.22 Million	21,743 Added 6.52%	355,167 $13.1 Million
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $2.18 Million - $3.17 Million	60,304 Added 22.08%	333,424 $16.8 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $373,808 - $616,630	15,320 Added 5.94%	273,120 $9.97 Million
Q4 2017 Feb 13, 2018	SELL	$18.5 - $28.6 $28,231 - $43,643	-1,526 Reduced 0.59%	257,800 $7.3 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $523,884 - $691,956	35,760 Added 16.0%	259,326 $5.02 Million
Q2 2017 Aug 14, 2017	BUY	N/A	223,566	223,566 $3.74 Million

Others Institutions Holding AXGN

# of Institutions

129

Shares Held

35.8M

Call Options Held

79.1K

Put Options Held

500

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $583M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Axogen, Inc. Transaction History